Q4 2022 13F Holders as of 12/31/2022
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
170M
-
Number of holders
-
123
-
Total 13F shares, excl. options
-
105M
-
Shares change
-
+392K
-
Total reported value, excl. options
-
$588M
-
Value change
-
+$1.17M
-
Put/Call ratio
-
0.58
-
Number of buys
-
61
-
Number of sells
-
-50
-
Price
-
$5.60
Significant Holders of Seres Therapeutics, Inc. - COMMON STOCK (MCRB) as of Q4 2022
151 filings reported holding MCRB - Seres Therapeutics, Inc. - COMMON STOCK as of Q4 2022.
Seres Therapeutics, Inc. - COMMON STOCK (MCRB) has 123 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 105M shares
of 170M outstanding shares and own 61.66% of the company stock.
Largest 10 shareholders include Flagship Pioneering Inc. (23.1M shares), FMR LLC (18.7M shares), FEDERATED HERMES, INC. (18.1M shares), JANUS HENDERSON GROUP PLC (11.2M shares), BlackRock Inc. (6.46M shares), VANGUARD GROUP INC (6.09M shares), STATE STREET CORP (4.56M shares), Eversept Partners, LP (2.2M shares), GEODE CAPITAL MANAGEMENT, LLC (1.59M shares), and Kynam Capital Management, LP (777K shares).
This table shows the top 123 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.